Xeris Pharmaceuticals
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.gvokeglucagon.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Xeris Pharmaceuticals
Gvoke offers the Gvoke HypoPen®, a ready-to-use emergency glucagon injection designed to treat severe hypoglycemia in individuals with diabetes aged 2 and above. This simple, premixed injection can quickly and safely raise very low blood sugar levels. Gvoke targets patients at risk of low blood sugar, including those on insulin or sulfonylureas, providing a reliable tool for managing critical situations. The product is also supported by resources for patients and healthcare providers, ensuring proper use and accessibility.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Xeris Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Xeris Pharmaceuticals launches new products
Check if Xeris Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if Xeris Pharmaceuticals had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Xeris Pharmaceuticals has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Xeris Pharmaceuticals recently announced quarterly report
Check out if Xeris Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Xeris Pharmaceuticals
Xeris Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Xeris Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Xeris Pharmaceuticals
Compare insights from companies similar to Xeris Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Xeris Pharmaceuticals
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Xeris Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xeris Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xeris Pharmaceuticals.
Xeris Pharmaceuticals Tech Stack
A closer look at the technologies used by Xeris Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xeris Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Gvoke offers the Gvoke HypoPen®, a ready-to-use emergency glucagon injection designed to treat severe hypoglycemia in individuals with diabetes aged 2 and above. This simple, premixed injection can quickly and safely raise very low blood sugar levels. Gvoke targets patients at risk of low blood sugar, including those on insulin or sulfonylureas, pr... Read More
